publication venue for
- Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: history, methodology and applications. 1-16. 2020
- Optimization of a paediatric fixed dose combination mini-tablet and dosing regimen for the first line treatment of tuberculosis. 1-7. 2019
- Computer simulations for bioequivalence trials: Selection of analyte in BCS class II and IV drugs with first-pass metabolism, two metabolic pathways and intestinal efflux transporter. 193-203. 2018
- Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation. 200-207. 2018
- Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach.. 258-269. 2018
- Population pharmacokinetics of oxaliplatin after intraperitoneal administration with hyperthermia in Wistar rats. 22-30. 2018
- Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits. 123-132. 2018
- Comparison of segmental-dependent permeability in human and in situ perfusion model in rat.. 191-196. 2017
- PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen.. 1-10. 2017
- Development of an ion-pair to improve the colon permeability of a low permeability drug: Atenolol. 334-340. 2016
- Drug gastrointestinal absorption in rat: strain and gender differences. 198-203. 2015
- Semi-physiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid. European journal of pharmaceutical sciences. 86-94. 2015
- Validation of a semi-physiological model for caffeine in healthy subjects and cirrhotic patients.. 57-63. 2015
- Validation of phenol red versus gravimetric method for water reabsorption correction and study of gender differences in Doluisio's absorption technique. 105-110. 2014
- Ion-pair strategy for enabling amifostine oral absorption: Rat in situ and in vivo experiments. 499-504. 2013
- Oligochitosan polyplexes as carriers for retinal gene delivery. 323-331. 2013
- Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model.. 290-291. 2011
- Computer simulations for bioequivalence trials (3): drugs with first-pass metabolism and two metabolic pathways 2010
- Unique pharmacology of Kar-2, a potential anti-cancer agent: absorption modelling and selective mitotic spindle targeting. 11-19. 2009
- Computer simulations of bioequivalence trials: Selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Part II. Non-linear kinetics. 1-10. 2008
- Computer simulations of bioequivalence trials: Selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Linear kinetics (I). 1-10. 2008
- Unique pharmacology of KAR-2, a potential anti-cancer. 1-12. 2008
- Mixed-effects Modelling of the Interspecies Pharmacokinetic Scaling of Pegylated Human Erythropoietin. 465-475. 2005
- Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models. 347-356. 2004
- PAMPA - a Drug Absorption in vitro Model 7. Comparing Rat in situ, Caco-2, and PAMPA Permeability of Fluoroquinolones. 429-441. 2004
- PAMPA a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. 429-441. 2004